Skip to main content
. Author manuscript; available in PMC: 2020 Oct 27.
Published in final edited form as: Nat Mater. 2020 Apr 27;19(8):910–920. doi: 10.1038/s41563-020-0674-z

Figure 2. Synthesis and characterization of nanoformulations of CAB and prodrugs.

Figure 2.

(a) Morphological assessment of NCAB, NMCAB, NM2CAB, and NM3CAB by SEM. Data was independently reproduced three times. (b) The stability of CAB and prodrug nanoformulations was evaluated over 98 days following manufacture at room temperature, 4 ºC, and 37 ºC as determined by size (nm), polydispersity index (PDI), and zeta potential (mV). Data are expressed as the mean ± SEM for N = 3 biological replicates.